Abstract: A synthetic gene characterised in that it codes for the expression of urogastrone or a sub-unit thereof is disclosed.The production thereof by the assembly and ligation of a number of nucleotide blocks is also disclosed, as are corresponding plasmid recombinants, transformed cells and the production thereof.The expression of urogastrone is further disclosed.Urogastrone is a polypeptide hormore (protein) which may be isolated in small amounts from human urine. It has an application in the treatment of ulcers and in the promotion of wound healing. The present invention provides a more viable commercial production.
Type:
Grant
Filed:
September 13, 1984
Date of Patent:
January 12, 1988
Assignee:
G. D. Searle & Co.
Inventors:
Michael A. W. Eaton, Michael T. Doel, Norman H. Carey, John C. Smith, David M. J. Lilley, Leslie D. Bell